. – I voted against this objection. The European Commission has not overstepped its mandate in extending the approval licenses of these 10 active substances. Under Article 17 of Regulation 1107/2009, the European Commission is obliged to extend the license of active substances ʻWhere for reasons beyond the control of the applicant it appears that the approval is likely to expire before a decision has been taken on renewal, a decision shall be adopted in accordance with the regulatory procedure referred to in Article 79(3), postponing the expiry of the approval period for that applicant for a period sufficient to examine the application.’ The European Ombudsman Decision in case 687/2018/TE found that the Commission is obliged to extend the approval of active substances if it does not complete a reassessment in time, provided the delay was not caused by the manufacturer of the product. Where concerns about chemicals are raised we need a risk management decision in a timely fashion. Furthermore, it is regrettable that the Commission continues to bundle together extension approvals. This practice should change so that we treat each substance individually and extend each license individually.